Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Keros Therapeutics Inc.

    NASDAQ: KROS · Real-Time Price · USD
    14.47
    0.05 (0.35%)
    At close: Aug 15, 2025, 1:15 PM

    Keros Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 3.55M 151K n/a 20.1M
    Cost of Revenue
    		 1.23M 815K 1.61M 898K
    Gross Profit
    		 3.55M -664K -1.61M 19.2M
    Operating Income
    		 -210.83M -169.94M -114.79M -56.37M
    Interest Income
    		 n/a n/a 1K n/a
    Pretax Income
    		 -187.05M -152.99M -104.68M -56.73M
    Net Income
    		 -187.35M -152.99M -104.68M -58.74M
    Selling & General & Admin
    		 40.75M 34.83M 27.52M 21.33M
    Research & Development
    		 173.63M 135.26M 87.27M 55.14M
    Other Expenses
    		 n/a n/a -7.08M -356K
    Operating Expenses
    		 214.38M 170.09M 107.71M 76.47M
    Interest Expense
    		 n/a n/a 1K 4K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 214.38M 170.09M 107.71M 76.47M
    Income Tax Expense
    		 300K n/a 1K 2.01M
    Shares Outstanding (Basic)
    		 37.44M 29.45M 25.24M 23.33M
    Shares Outstanding (Diluted)
    		 37.44M 29.45M 25.24M 23.33M
    EPS (Basic)
    		 -5 -5.2 -4.15 -2.52
    EPS (Diluted)
    		 -5 -5.2 -4.15 -2.52
    EBITDA
    		 -185.82M -152.18M -103.06M -56.37M
    EBIT
    		 -187.05M -152.99M -104.68M -56.73M
    Depreciation & Amortization
    		 1.23M 815K 1.61M 898K

    Add to Watchlist